Pooled Analysis of Responder Rates and Seizure Freedom from Phase III Clinical Trials of Adjunctive Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist (PD3.010)

Clinical and Laboratory Hematologic Findings in Patients Receiving Repeated-Dose Injectable HPBCD-Diclofenac for Acute Postoperative Pain: Pooled Analysis of Two Randomized Controlled Phase III Clinical Trials

Journal of Anesthesia & Clinical Research ◽

10.4172/2155-6148.1000538 ◽

2015 ◽

Vol 06 (07) ◽

Cited By ~ 1

Author(s):

Tong J Gan Neil Singla

Keyword(s):

Clinical Trials ◽

Postoperative Pain ◽

Pooled Analysis ◽

Phase Iii ◽

Repeated Dose ◽

Acute Postoperative Pain ◽

Randomized Controlled ◽

PR4 IMPACT OF CLINICALLY MEANINGFUL REDUCTION IN DYSPAREUNIA ON HEALTH-RELATED QUALITY OF LIFE AMONG ENDOMETRIOSIS PATIENTS: A POOLED ANALYSIS OF TWO PHASE III CLINICAL TRIALS

Value in Health ◽

10.1016/j.jval.2020.04.1231 ◽

2020 ◽

Vol 23 ◽

pp. S328

Author(s):

S.K. Agarwal ◽

A.M. Soliman ◽

R. Pokrzywinski ◽

K.S. Coyne

Keyword(s):

Quality Of Life ◽

Clinical Trials ◽

Pooled Analysis ◽

Phase Iii ◽

Health Related Quality ◽

Two Phase ◽

Related Quality ◽

Health Related

The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): Pooled analysis of the two STBSG-EORTC phase III clinical trials

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.10525 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 10525-10525 ◽

Cited By ~ 31

Author(s):

A. Le Cesne ◽

M. Van Glabbeke ◽

P. J. Woll ◽

V. H. Bramwell ◽

P. G. Casali ◽

...

Keyword(s):

Clinical Trials ◽

Adjuvant Chemotherapy ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Pooled Analysis ◽

Phase Iii ◽

High Grade ◽

Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist, Prolongs Time to Seizure Recurrence in Patients with Epilepsy: Results of Pooled Phase III Clinical Trial Data (S56.005)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.s56.005 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. S56.005-S56.005 ◽

Cited By ~ 1

Author(s):

A. Laurenza ◽

J. French ◽

A. Gil-Nagel ◽

R. Guerrini ◽

D. Squillacote ◽

...

Keyword(s):

Clinical Trial ◽

Receptor Antagonist ◽

Ampa Receptor ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Seizure Recurrence ◽

Phase Iii Clinical Trial ◽

Patients With Epilepsy

Postoperative opioid sparing with injectable hydroxypropyl-β-cyclodextrin-diclofenac: pooled analysis of data from two Phase III clinical trials

Journal of Pain Research ◽

10.2147/jpr.s106578 ◽

2016 ◽

Vol Volume 10 ◽

pp. 15-29 ◽

Cited By ~ 3

Author(s):

Tong Gan ◽

Neil Singla ◽

Stephen E Daniels ◽

Douglas Hamilton ◽

Peter Lacouture ◽

...

Keyword(s):

Clinical Trials ◽

Pooled Analysis ◽

Phase Iii ◽

Two Phase ◽

Beta Cyclodextrin ◽

Opioid Sparing ◽

Hydroxypropyl Beta Cyclodextrin

Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist, Prolongs Time to Seizure Recurrence in Patients with Epilepsy: Results of Pooled Phase III Clinical Trial Data (IN5-1.004)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.in5-1.004 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. IN5-1.004-IN5-1.004

Author(s):

A. Laurenza ◽

J. French ◽

A. Gil-Nagel ◽

R. Guerrini ◽

D. Squillacote ◽

...

Keyword(s):

Clinical Trial ◽

Receptor Antagonist ◽

Ampa Receptor ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Seizure Recurrence ◽

Phase Iii Clinical Trial ◽

Patients With Epilepsy

Cardiovascular safety of hydroxypropyl-β-cyclodextrin–diclofenac in the management of acute postsurgical pain: a pooled analysis of 2 randomized, double-blind, placebo- and active comparator–controlled phase III clinical trials

Journal of Clinical Anesthesia ◽

10.1016/j.jclinane.2016.01.020 ◽

2016 ◽

Vol 31 ◽

pp. 249-258 ◽

Cited By ~ 11

Author(s):

Tong J. Gan ◽

Neil Singla ◽

Stephen E. Daniels ◽

Peter G. Lacouture ◽

Lauren H. Min ◽

...

Keyword(s):

Clinical Trials ◽

Pooled Analysis ◽

Phase Iii ◽

Cardiovascular Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Active Comparator ◽

Postsurgical Pain ◽

Characteristics of a Chronic Cough Population Participating in Two Large Phase III Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2360 ◽

2021 ◽

Author(s):

P. Dicpinigaitis ◽

L. McGarvey ◽

A.H. Morice ◽

J. Smith ◽

S.S. Birring ◽

...

Keyword(s):

Clinical Trials ◽

Receptor Antagonist ◽

Chronic Cough ◽

Phase Iii ◽

P2x3 Receptor ◽

Large Phase

Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.101 ◽

2017 ◽

Vol 1 ◽

pp. s102

Author(s):

Nuria Albareda ◽

Noah Rosenberg ◽

Sandra Roth ◽

Ilonka Zsolt ◽

Theodore Rosen ◽

...

Keyword(s):

Clinical Trials ◽

Antibacterial Agent ◽

Pediatric Patients ◽

Pooled Analysis ◽

Phase Iii ◽

Topical Antibacterial

Abstract Not Available

Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures: A Dose Response Analysis from Phase III Studies (P06.117)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.p06.117 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. P06.117-P06.117 ◽

Cited By ~ 4

Author(s):

L. Kramer ◽

E. Perucca ◽

E. Ben-Menachem ◽

P. Kwan ◽

J. Shih ◽

...

Keyword(s):

Receptor Antagonist ◽

Ampa Receptor ◽

Dose Response ◽

Adjunctive Therapy ◽

Phase Iii ◽

Response Analysis ◽

Phase Iii Studies